1. Home
  2. TNXP
  3. TNXP News

Latest Tonix Pharmaceuticals Holding Corp. (TNXP) News on November 27, 2025

TNXP

MT Newswires

3 days ago

Pharmaceuticals Receives FDA Clearance to Proceed With Phase 2 Study of TNX-102 SL for Major Depressive Disorder

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder
TNXP

GlobeNewswire

3 days ago

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder

TNXP

MT Newswires

10 days ago

Tonix Pharmaceuticals Commercially Launches Fibromyalgia Treatment in US

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment
TNXP

GlobeNewswire

10 days ago

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

Several Insiders Invested In Tonix Pharmaceuticals Holding Flagging Positive News
TNXP

Simply Wall St.

15 days ago

Several Insiders Invested In Tonix Pharmaceuticals Holding Flagging Positive News

Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights
TNXP

GlobeNewswire

16 days ago

Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference
TNXP

GlobeNewswire

21 days ago

Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection
TNXP

GlobeNewswire

23 days ago

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection

Tonix Pharmaceuticals Holding Corp (TNXP) Showcases Promising TNX-801 Vaccine Data
TNXP

Insider Monkey

a month ago

Tonix Pharmaceuticals Holding Corp (TNXP) Showcases Promising TNX-801 Vaccine Data

Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital

Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence

Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025

Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
TNXP

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation

Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025
TNXP

GlobeNewswire

2 months ago

Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals to Join Russell Indexes

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
TNXP

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

TNXP

MT Newswires

5 months ago

Top Premarket Decliners

TNXP

MT Newswires

5 months ago

Tonix Pharmaceuticals Plans Potential Share Sale of Up to $150 Million; Stock Falls Premarket

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia…
TNXP

Zacks Small Cap Research

6 months ago

TNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia…

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
TNXP

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
TNXP

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
TNXP

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
TNXP

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?
TNXP

Insider Monkey

8 months ago

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP: No AdCom Required for TNX-102 SL NDA…
TNXP

Zacks Small Cap Research

8 months ago

TNXP: No AdCom Required for TNX-102 SL NDA…

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
TNXP

ACCESS Newswire

8 months ago

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

TNXP

ACCESS Newswire

8 months ago

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP

MT Newswires

8 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

TNXP

MT Newswires

8 months ago

Sector Update: Health Care

TNXP

MT Newswires

8 months ago

Update: Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up

TNXP

MT Newswires

8 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

TNXP

MT Newswires

8 months ago

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread
TNXP

ACCESS Newswire

8 months ago

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
TNXP

GlobeNewswire

8 months ago

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
TNXP

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

Life Sciences Investor Forum Agenda Announced for March 13th
TNXP

GlobeNewswire

9 months ago

Life Sciences Investor Forum Agenda Announced for March 13th

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
TNXP

ACCESS Newswire

9 months ago

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
TNXP

GlobeNewswire

9 months ago

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
TNXP

GlobeNewswire

9 months ago

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week
TNXP

Insider Monkey

9 months ago

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday
TNXP

Insider Monkey

9 months ago

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday

A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market
TNXP

GuruFocus.com

9 months ago

A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market

Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results
TNXP

GuruFocus.com

9 months ago

Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
TNXP

GlobeNewswire

9 months ago

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
TNXP

GlobeNewswire

9 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…
TNXP

Zacks Small Cap Research

9 months ago

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…

TNXP

MT Newswires

10 months ago

Tonix Pharmaceuticals Rises After Preliminary 2024 Results

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500
TNXP

Clinical Trials Arena

10 months ago

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
TNXP

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases
TNXP

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
TNXP

GlobeNewswire

10 months ago

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
TNXP

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
TNXP

GlobeNewswire

10 months ago

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

TNXP

MT Newswires

a year ago

Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

TNXP

MT Newswires

a year ago

Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
TNXP

ACCESSWIRE

a year ago

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…
TNXP

Zacks Small Cap Research

a year ago

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
TNXP

ACCESSWIRE

a year ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Tonix Pharma Partners for Vaccine Clinical Trial
TNXP

TipRanks

a year ago

Tonix Pharma Partners for Vaccine Clinical Trial

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

TNXP

MT Newswires

a year ago

Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals
TNXP

GuruFocus.com

a year ago

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

TNXP

MT Newswires

a year ago

Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

Tonix Pharma Enhances Drug Development with AI Partnership
TNXP

TipRanks

a year ago

Tonix Pharma Enhances Drug Development with AI Partnership

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
TNXP

ACCESSWIRE

a year ago

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
TNXP

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

Share on Social Networks: